Metabolic•Clinical Trials

Retatrutide

Retatrutide is a triple agonist (GLP-1, GIP, and Glucagon) known as the "King" of metabolic peptides. It engages three distinct receptor pathways for maximum fat burning and metabolic control.

Mechanism of Action

Activates GLP-1 (appetite), GIP (metabolism/insulin), and Glucagon (energy expenditure/liver fat). The addition of Glucagon agonism significantly increases resting energy expenditure.

Key Benefits

Highest potency for weight loss
Increases resting energy expenditure
Rapid reduction in liver fat
Improved lipid profile

Research Protocol

Loading Phase
2mg weekly
Maintenance
Titrate up to 12mg weekly
Experimental. Potent effects on heart rate require careful monitoring.

Chemical Properties

FormulaC221H342N46O68
Mol. Weight4731.33 g/mol

Side Effects & Risks

  • •Increased heart rate
  • •Nausea
  • •Skin sensitivity (Allodynia)
  • •Appetite suppression

Amino Acid Sequence

Triple Agonist Peptide
HomeLibraryResearchFavoritesToolsVisuals